PVLA (Pieris Pharma) Sof foyda

PVLA (Pieris Pharmaceuticals, Inc.) - kompaniyaning tovar belgisi

Pieris Pharmaceuticals (PVLA) saraton bilan kurashish uchun to'qimalarga antitanachalardan ko'ra samaraliroq kirib boruvchi ixcham antikalin oqsillarini yaratish uchun noyob texnologiyaga ega. Kompaniya onkologiya va respirator kasalliklar uchun ilg'or davolash usullarini ishlab chiqadi va hamkorlar bilan litsenziyalash shartnomalari orqali daromad keltiradi. Ushbu kunlik narxlar grafigi -0.06 miqdoridagi alohida foyda darajasini aks ettiradi. Rahbariyat hozirda klinik maqsadlarni yangilayotgan bir paytda, bozor restructuring muvaffaqiyatlarining aniq natijalarini ehtiyotkorlik bilan kutmoqda.

PVLA (Pieris Pharmaceuticals) Sof foyda tarixi 04.07.2022dan 31.10.2026gacha

Pieris Pharmaceuticals, Inc. (PVLA) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Pieris Corp|PVLA - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Pieris Corp|PVLA - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Pieris Pharmaceuticals|PVLA - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi pieris.com|PVLA - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Pieris Pharmaceuticals|PVLA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Pieris Pharma|PVLA - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Pieris Corp|PVLA - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Pieris Pharmaceuticals|Shoshilinch likvidlik pieris.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
PVLA - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:Pieris Pharmaceuticals
Pieris Pharmaceuticals Inc asosiy tovari

Anti-kalin proteinlarini ishlab chiquvchi Pieris Pharmaceuticals (PVLA) uchun kompaniyaning hisobotdagi foydasi uning ilmiy tadqiqotlarini monetizatsiya qilish samaradorligini ko'rsatadi. Ushbu ko'rsatkich kvartal hisobotlarga xos bo'lgan vaqt oraliqlarini bartaraf etgan holda, daromad generatsiyasining kunlik sur'atini o'lchaydi. Mazkur metrika biznesning narxlarni inflyatsiyaga moslashtirish qobiliyatini aks ettiradi. Ushbu narx harakati sog'liqni saqlash gigantlari bilan tuzilgan sherikliklarning moliyaviy barqarorligini ifodalaydi. Barqaror tendentsiya emitentning joriy makrotsikl doirasidagi to'lov qobiliyatini tasdiqlaydi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Tourmaline Bio Inc (TRML) - Kompaniyaning sof daromadi|PGEN - Kompaniyaning sof foydasi|Soliqdan keyingi foyda PHAR|NKTR: Sof foyda|UPB - Sof moliyaviy natija|ZBIO (Zenas Biopharma) - Sof foyda|Kompaniyaning sof daromadi Immunome Inc IMNM|Kompaniyaning sof foydasi Gossamer Corp (GOSS)|KALV (KalVista Corp) - Yakuniy foyda|Sof foyda SEPN (Septerna Inc)|Sof moliyaviy natija savarapharma.com (SVRA)|RIGL - Kompaniyaning sof foydasi|Sof moliyaviy natija AnaptysBio Inc ANAB|ATXS (Astria Pharma) - Sof daromad|enGene Corp - Yakuniy foyda|Kompaniyaning sof foydasi RAPT Therapeutics, Inc.|Aerovate - Soliqdan keyingi foyda|Sof foyda ACRS|KYTX (Kyverna Therapeutics Inc.) - Yakuniy foyda|Sof foyda TLSA (Tiziana Life Sciences PLC)|Sof foyda Cabaletta Bio Inc CABA|VTYX - Kompaniyaning sof foydasi|Yakuniy foyda THTX (theratech.com)|Avalo Therapeutics (AVTX) - Kompaniyaning sof foydasi|Sof daromad Eledon Pharmaceuticals Inc.|AGEN (Agenus Inc) - Sof foyda|Sof foyda Climb Bio, Inc|Sof foyda ZURA|Sof daromad atyrpharma.com ATYR|Sof foyda ADAG (Adagene Inc.)|ImageneBio (IMA) - Kompaniyaning sof daromadi|STTK: Sof daromad|EQ - Sof foyda|CNTB (connectbiopharm.com) - Sof daromad|IMUX: Soliqlar to‘langandan keyingi foyda|ATRA (Atara Biotherapeutics, Inc.) - Sof foyda|InflaRx GmbH (IFRX) - Sof moliyaviy natija|Sof foyda XFOR|Sof daromad adicetbio.com ACET|Sof foyda CELU (Celularity)|Sof foyda inmunebio.com INMB|BRNS - Kompaniyaning sof foydasi|KZR: Kompaniyaning sof foydasi|SAB Biotherapeutics, Inc (SABS) - Kompaniyaning sof foydasi|AKTX - Sof moliyaviy natija|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|Q32 Bio Corp - Soliqdan keyingi foyda|Sof daromad GOVX (GeoVax)|Kompaniyaning sof foydasi EDSA (Edesa Biotech Inc)|Kompaniyaning sof foydasi iBio Corp IBIO|Carisma Therapeutics Inc - Kompaniyaning sof foydasi|XTL Biopharmaceuticals - Sof foyda|BOLT - Sof foyda|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Soliqdan keyingi foyda APVO (Aptevo Therapeutics Inc.)|AIM (AIM ImmunoTech) - Sof foyda|ADTX: Yakuniy foyda|Sof foyda GRI|Sof foyda xortx.com (XRTX)|Kompaniyaning sof foydasi Vyome Holdings HIND|Yakuniy foyda REVB|INDP - Kompaniyaning sof foydasi|BiondVax Pharmaceuticals (SCNI) - Sof daromad|CALI: Sof foyda|Affimed N.V. (AFMD) - Sof foyda|Sof daromad ALLK|HOOK: Yakuniy foyda|Sof foyda IGMS|Sof moliyaviy natija iTeos Pharma|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|TCBP - Sof daromad|THRD - Kompaniyaning sof foydasi